Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, January 25, 2023
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
[ Wed, Jan 25th 2023
] - WOPRAI
Bill Sutherland Maintained (AMED) at Strong Buy with Decreased Target to $120 on, Jan 25th, 2023
Bill Sutherland of Benchmark, Maintained "Amedisys, Inc." (AMED) at Strong Buy with Decreased Target from $135 to $120 on, Jan 25th, 2023.
Bill has made no other calls on AMED in the last 4 months.
There are 10 other peers that have a rating on AMED. Out of the 10 peers that are also analyzing AMED, 3 agree with Bill's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $85 on, Thursday, January 5th, 2023
- Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $106 on, Friday, November 11th, 2022
- John Ransom of "Raymond James" Downgraded from Buy to Hold on, Thursday, October 27th, 2022
These are the ratings of the 7 analyists that currently disagree with Bill
- Jonathan Yong of "Credit Suisse" Maintained at Buy with Decreased Target to $115 on, Monday, January 23rd, 2023
- Colin Rusch of "Oppenheimer" Maintained at Buy with Decreased Target to $125 on, Thursday, January 19th, 2023
- Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $139 on, Monday, October 31st, 2022
- David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $130 on, Friday, October 28th, 2022
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $145 on, Friday, October 28th, 2022
- Sarah James of "Barclays" Maintained at Buy with Decreased Target to $126 on, Friday, October 28th, 2022
- Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $165 on, Monday, October 24th, 2022
